PAUL FAGAN: Open Payments
NPI 1336437367 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 28 payments from 9 companies in 2025. Trend: 2023 $723 · 2024 $827 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $170 |
| Virtus Pharmaceuticals LLC | 5 | $111 |
| Collegium Pharmaceutical, Inc. | 4 | $87 |
| Saluda Medical Americas, Inc. | 2 | $57 |
| Forte Bio-Pharma LLC | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Boston Scientific Corporation | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Valinor Pharma, LLC | 1 | $14 |
Products named: RELISTOR, LEVORPHANOL TARTRATE, Belbuca, Evoke, PROLATE, JOURNAVX, WaveWriter Alpha Prime 16, XTAMPZA.
Industry payments across NC — which companies pay providers there.
